UBS Group Lowers Oklo (NYSE:OKLO) Price Target to $60.00

Oklo (NYSE:OKLO) had its price target decreased by equities researchers at UBS Group from $95.00 to $60.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target would indicate a potential upside of 19.47% from the company’s current price.

Other analysts have also recently issued research reports about the company. Citigroup decreased their target price on Oklo from $95.00 to $73.50 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Texas Capital upgraded shares of Oklo to a “strong-buy” rating in a report on Tuesday, January 27th. Bank of America raised shares of Oklo from a “neutral” rating to a “buy” rating and lifted their price target for the company from $111.00 to $127.00 in a research report on Wednesday, January 21st. Cantor Fitzgerald reiterated an “overweight” rating and set a $122.00 price objective on shares of Oklo in a research note on Wednesday, March 18th. Finally, HC Wainwright reissued a “buy” rating and issued a $90.00 price objective on shares of Oklo in a research report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $84.30.

Oklo Trading Down 3.1%

Shares of OKLO opened at $50.22 on Thursday. Oklo has a twelve month low of $17.42 and a twelve month high of $193.84. The firm has a market capitalization of $8.72 billion, a P/E ratio of -69.75 and a beta of 0.80. The stock’s fifty day simple moving average is $68.12 and its 200 day simple moving average is $93.99.

Oklo (NYSE:OKLO) last posted its quarterly earnings results on Tuesday, March 17th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.10). During the same quarter in the previous year, the firm earned ($0.74) earnings per share. Sell-side analysts predict that Oklo will post -8.2 earnings per share for the current year.

Insider Transactions at Oklo

In other news, CFO Richard Craig Bealmear sold 72,090 shares of the firm’s stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $60.00, for a total transaction of $4,325,400.00. Following the completion of the sale, the chief financial officer directly owned 386,008 shares in the company, valued at $23,160,480. This trade represents a 15.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jacob Dewitte sold 231,657 shares of Oklo stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $99.25, for a total value of $22,991,957.25. Following the sale, the chief executive officer directly owned 827,019 shares in the company, valued at approximately $82,081,635.75. The trade was a 21.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 1,222,424 shares of company stock valued at $100,739,512. 18.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oklo

Several hedge funds and other institutional investors have recently bought and sold shares of OKLO. Plancorp LLC boosted its stake in shares of Oklo by 1.2% during the 3rd quarter. Plancorp LLC now owns 6,089 shares of the company’s stock valued at $680,000 after buying an additional 73 shares during the last quarter. Parkside Financial Bank & Trust grew its position in shares of Oklo by 3.7% during the third quarter. Parkside Financial Bank & Trust now owns 2,622 shares of the company’s stock worth $293,000 after buying an additional 94 shares in the last quarter. Prestige Wealth Management Group LLC increased its stake in shares of Oklo by 1.5% in the third quarter. Prestige Wealth Management Group LLC now owns 7,066 shares of the company’s stock worth $789,000 after buying an additional 101 shares during the last quarter. Meriwether Wealth & Planning LLC increased its stake in shares of Oklo by 2.7% in the fourth quarter. Meriwether Wealth & Planning LLC now owns 4,545 shares of the company’s stock worth $326,000 after buying an additional 120 shares during the last quarter. Finally, Rossby Financial LCC raised its holdings in Oklo by 75.0% in the third quarter. Rossby Financial LCC now owns 350 shares of the company’s stock valued at $41,000 after acquiring an additional 150 shares in the last quarter. 85.03% of the stock is currently owned by hedge funds and other institutional investors.

Key Oklo News

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Regulatory progress for the Aurora reactor program was reported, suggesting advancement on licensing milestones that de‑risk the company’s flagship project and its timeline to commercial revenue. Regulatory progress for Aurora
• Positive Sentiment: Oklo completed the acquisition of Atomic Alchemy to enter domestic production of medical and industrial isotopes, diversifying revenue potential beyond reactors and shortening a path to cash flow. The company also reiterated reactor progress in the same update. Oklo Acquisition And Reactor Progress Reframe Long Term Investor Debate
• Positive Sentiment: CEO and co‑founder Jacob DeWitte was appointed to the President’s Council of Advisors on Science and Technology (PCAST), a high‑profile government advisory role that can improve regulatory access and legitimacy for advanced nuclear projects. Oklo Co-Founder and CEO Appointed to Serve on President’s Council of Advisors on Science and Technology
• Neutral Sentiment: Analysts remain conflicted on Oklo alongside other utilities/energy names, reflecting divergent views on commercialization timelines and regulatory risk that increase short‑term volatility. Analysts Conflicted on These Utilities Names: Oklo Inc (OKLO) and PG&E (PCG)
• Neutral Sentiment: Comparative coverage with peers (e.g., Montauk Renewables) has appeared, useful for investors benchmarking Oklo’s valuation and business model but not a direct positive/negative catalyst. Critical Comparison: Montauk Renewables (NASDAQ:MNTK) and Oklo (NYSE:OKLO)
• Negative Sentiment: UBS cut its price target from $95 to $60 and set a “neutral” rating, signaling lower near‑term upside and contributing to selling pressure. Benzinga
• Negative Sentiment: B. Riley trimmed its price target to $92, another downward analyst revision that likely dampened sentiment despite longer‑term growth narratives. OKLO Price Target Trimmed to $92

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.